2011 - IPITA - Prague


This page contains exclusive content for the member of the following sections: TTS, IPITA. Log in to view.

Poster

1.192 - Endothelial cells promote pancreatic stem cell activation during islet regeneration

Presenter: J. D., Rivas-Carrillo1, ,
Authors: S.D. Rivas-Carrillo1, J. Kanamune2, A. Daneri-Navarro1, J. D. Rivas-Carrillo1

P-192

Endothelial cells promote pancreatic stem cell activation during islet regeneration

S.D. Rivas-Carrillo1, J. Kanamune2, A. Daneri-Navarro1, J. D. Rivas-Carrillo1
1 University of Guadalajara, Dept of Physiology, Labs of Immunology and Transplant, Guadalajara, Mexico; 2 Kyoto University Hospital, Dept of Transplant Surgery, Pancreas and Islet Transplantation Unit, Kyoto, Japan

Objectives:Diabetes is the clinical consequence of the loss of the majority of the ? cell population and failure to regenerate new pancreatic ?-cells. The current therapies based on ? cell replacement have failed to achieve ? cell renewal and thus, long-term insulin freedom. We have hypothesized that early rejection of endothelial within the islet grafts may seriously hampered islet regeneration of both native and islet grafts.

Methods: In the present study, we analyzed the role of endothelial cells in the activation of pancreatic stem cells during islet regeneration. Mice were pretreated with or without endothelial pharmacological ablation of endothelial cells, followed by an acute ? cell injury using a single intraperitoneal injection of streptozotocin.

We performed a comparative morphometric analyses within the recovered pancreata on days 3rd, 7th, 10th and 30th after streptozotocin injury, and thus stained for representative cell types, ? cell, endothelial and stem cells co-stained with BrdU. Blood glucose levels were measured continuously after injury to monitor the capacity of metabolic control.

Results: Morphometric analyses revealed an increased number over time of cells stained with a stem cell marker and BrdU marker in animals only injured with streptozotocin but no endothelial ablation. Notably, on day 10th stem cell marker dramatically decrease nearly basal levels, and instead numerous insulin-positive cells appeared. Intact vessels with cobblestone-shaped endothelial were observed in direct proportion with better outcomes, in both morphometric and metabolic parameters. In contrast, fewer insulin positive cells were found on pancreata, which were ablated ofendothelial cells, and showed an extensive collapse of the entire endocrine functions.

Conclusions: We have found that endothelial promote stem cell proliferation and islet regeneration after ? cell insult. We believe that preservation of endothelial cells may positively affect the process of pancreatic regeneration.

/

P-192

Endothelial cells promote pancreatic stem cell activation during islet regeneration

S.D. Rivas-Carrillo1, J. Kanamune2, A. Daneri-Navarro1, J. D. Rivas-Carrillo1
1 University of Guadalajara, Dept of Physiology, Labs of Immunology and Transplant, Guadalajara, Mexico; 2 Kyoto University Hospital, Dept of Transplant Surgery, Pancreas and Islet Transplantation Unit, Kyoto, Japan

Objectives:Diabetes is the clinical consequence of the loss of the majority of the ? cell population and failure to regenerate new pancreatic ?-cells. The current therapies based on ? cell replacement have failed to achieve ? cell renewal and thus, long-term insulin freedom. We have hypothesized that early rejection of endothelial within the islet grafts may seriously hampered islet regeneration of both native and islet grafts.

Methods: In the present study, we analyzed the role of endothelial cells in the activation of pancreatic stem cells during islet regeneration. Mice were pretreated with or without endothelial pharmacological ablation of endothelial cells, followed by an acute ? cell injury using a single intraperitoneal injection of streptozotocin.

We performed a comparative morphometric analyses within the recovered pancreata on days 3rd, 7th, 10th and 30th after streptozotocin injury, and thus stained for representative cell types, ? cell, endothelial and stem cells co-stained with BrdU. Blood glucose levels were measured continuously after injury to monitor the capacity of metabolic control.

Results: Morphometric analyses revealed an increased number over time of cells stained with a stem cell marker and BrdU marker in animals only injured with streptozotocin but no endothelial ablation. Notably, on day 10th stem cell marker dramatically decrease nearly basal levels, and instead numerous insulin-positive cells appeared. Intact vessels with cobblestone-shaped endothelial were observed in direct proportion with better outcomes, in both morphometric and metabolic parameters. In contrast, fewer insulin positive cells were found on pancreata, which were ablated ofendothelial cells, and showed an extensive collapse of the entire endocrine functions.

Conclusions: We have found that endothelial promote stem cell proliferation and islet regeneration after ? cell insult. We believe that preservation of endothelial cells may positively affect the process of pancreatic regeneration.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada